Baron & Budd Named One of the Top Law Firms for Female Attorneys

Firm named as one of the top law firms for female attorneys by Law360’s 2019 Glass Ceiling Report

DALLAS–(BUSINESS WIRE)–The national law firm of Baron & Budd is pleased to announce it was ranked as one of the best law firms for female attorneys. Law360’s 2019 Glass Ceiling report looks at law firms based on their attorney headcount and ranks them by their percentage of female partners and nonpartners. Law360 says it lists the 70 firms “who are leading the pack in representing women at all levels.”

Law360’s research indicates that women represent only 36.3% of attorneys at firms and women represent only 24.8% of partners, which suggests fewer women are rising through the ranks. Of the 25 shareholders at Baron & Budd, nearly one third are women. The firm currently has 58 attorneys that are not shareholders. Of those attorneys, 25 are women.

“While we are very proud to make this list, we know there is always room for improvement and we hope to keep climbing up the rankings by continuing to hire extremely talented and qualified women to represent our firm,” said Baron and Budd president and managing shareholder, Russell Budd. “We hope to continue to be an example of gender diversity in this industry and let women know that they have equal access to the path of success.”

About Baron & Budd, P.C.

Baron & Budd, P.C., is among the largest and most accomplished plaintiffs’ law firms in the country. With more than 40 years of experience, Baron & Budd has the expertise and resources to handle complex litigation throughout the United States. As a law firm that takes pride in remaining at the forefront of litigation, Baron & Budd has spearheaded many significant cases for hundreds of entities and thousands of individuals. Since the firm was founded in 1977, Baron & Budd has achieved substantial national acclaim for its work on cutting-edge litigation, trying hundreds of cases to verdict and settling tens of thousands of cases in areas of litigation as diverse as dangerous pharmaceuticals and defective medical devices, asbestos and mesothelioma, environmental contamination, fraudulent banking practices, motor vehicles, employment, and other consumer fraud issues.